Cerebrovascular Disease News and Research

RSS

Cerebrovascular disease is a group of brain dysfunctions related to disease of the blood vessels supplying the brain. Hypertension is the most important cause; it damages the blood vessel lining, endothelium, exposing the underlying collagen where platelets aggregate to initiate a repairing process which is not always complete and perfect. Sustained hypertension permanently changes the architecture of the blood vessels making them narrow, stiff, deformed, uneven and more vulnerable to fluctuations in blood pressure.

New clinical trial to evaluate efficacy of stem cell product in patients disabled with chronic stroke

A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston.

16 May 2017

Gut microbiome may play key role in pathology of common cerebrovascular disease

Bacteria in the gut microbiome drive the formation of cerebral cavernous malformations (CCMs), clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures, according to new research published this week in Nature by researchers from the Perelman School of Medicine at the University of Pennsylvania.

10 May 2017

Sugary drinks may impact memory and diet alternatives could cause dementia

New research, published in both Alzheimer's & Dementia and Stroke indicate that drinking sugary drinks regularly may lead to a reduction in the size of the brain and poorer memory.

21 Apr 2017

WHO classifies stroke as neurological disease

The medical rationale for stroke being a neurological condition has always been compelling. We therefore welcome the latest decision by the Department of Statistics at the WHO to move the thematic block of cerebrovascular diseases from the circulatory diseases chapter to diseases of the nervous system," noted Prof Raad Shakir, head of the WHO Neurology Topic Advisory Group and President of the World Federation of Neurology.

6 Apr 2017

Study finds 78% postoperative stroke reduction with ‘no-touch’ beating heart bypass surgery

A landmark study led by Prof. Michael P. Vallely, MBBS, PhD, FRACS, of Sydney Heart and Lung Surgeons and the University of Sydney will be published in the February 28, 2017 issue of the Journal of the American College of Cardiology.

27 Feb 2017

Could pathogen infection really lead to Alzheimer’s?

New concepts of infectious disease are evolving with the realization that pathogens are key players in the development of progressive chronic diseases that originally were not thought to be infectious. Infection is well-known to be associated with numerous neurological diseases for which...

12 Jan 2017

Research findings cement link between kidney damage and cognitive functioning

People with kidney disease are at high risk of cognitive impairment, but the nature of this relationship remains uncertain.

18 Nov 2016

QUT study explores burden of foot disease on Australian health system

The "silent burden" of foot disease afflicts one in ten hospital patients, costing taxpayers billions and filling nearly 5,000 hospital beds each night, according to QUT research.

15 Nov 2016

USPSTF recommends use of low- to moderate-dose statins for preventing CVD events in adults

The U.S. Preventive Services Task Force has issued a recommendation statement regarding the use of statins for primary prevention of cardiovascular disease in adults. The report appears in the November 15 issue of JAMA.

14 Nov 2016

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine.

9 Nov 2016

Scientists outline criteria for assessing vascular cognitive impairment in post-mortem brain tissue

New research, led by academics at the University of Bristol, has outlined the first validated set of pathological criteria for assessing the likelihood that cognitive impairment was caused by vascular disease.

7 Sep 2016

CPAP treatment offers no cardiovascular benefit in OSA patients with heart disease risk

More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea (OSA).

30 Aug 2016

Maternal placental syndromes increase short-term risk of developing cardiovascular disease

The short-term risk of developing cardiovascular disease following a first pregnancy is higher for women experiencing placental syndromes and a preterm birth or an infant born smaller than the usual size, a University of South Florida study reports.

27 Jul 2016

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.

11 Jul 2016

Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher

Postpartum depression (PPD) is reported to occur in 10-15% of delivering women with an estimated 400,000 women affected annually in the US. It is the most common complication of childbirth and is a significant public health concern.

11 Jul 2016

Brain vessel diseases may contribute to Alzheimer's dementia

While strokes are known to increase risk for dementia, much less is known about diseases of large and small blood vessels in the brain, separate from stroke, and how they relate to dementia.

4 Jul 2016

Shift work alters internal body clock and leads to strokes, serious brain implications

Statistics show that some 15 million Americans don't work the typical nine-to-five. These employees (or shift workers), who punch in for graveyard or rotating shifts, are more prone to numerous health hazards, from heart attacks to obesity, and now, new research, published in Endocrinology, shows shift work may also have serious implications for the brain.

2 Jun 2016

Penn researchers discover molecular mechanism that underlies common cerebrovascular disease

Cerebral cavernous malformations (CCMs) are clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures, yet exactly how they form is somewhat of a mystery. Now, a team from the Perelman School of Medicine at the University of Pennsylvania has discovered the molecular mechanism that underlies this common cerebrovascular disease. They published their results this week online ahead of print in Nature.

31 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Diffusion tensor imaging ‘should be routine’ in SVD assessment

Gait speed and microstructural brain damage may be the best indicators of mortality risk in patients with small vessel disease, say researchers.

4 Feb 2016